Home » Topics » Regulatory

Regulatory
RSS

OxyContin labeling changes reflect new FDA warnings

July 27, 2001

Use of BTK inhibitor LFM-A13 for inhibiting platelet aggregation

July 25, 2001

SciClone's lead ISE approved for cancer indication in the Philippines

July 24, 2001

Texas Biotechnology receives approvable letter from FDA for expanded argatroban indication

July 23, 2001

FDA approves changes in Copaxone labeling

July 23, 2001

Clinical study of VNS for rapid cycling bipolar disorder cleared by U.S. authorities

July 23, 2001

FDA approves study of vagus nerve stimulation for migraine

July 23, 2001

First launch for diclofenac gel formulation for actinic keratoses

July 20, 2001

Therapy of psoriasis with anti-TNF-alpha antibodies

July 19, 2001

Baxter receives EMEA approval for Ceprotin

July 19, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...